New WHO recommendations will speed detection and improve treatment of multidrug resistant tuberculosis (MDR-TB) through use of a new rapid diagnostic test and a shorter, cheaper treatment regimen. The novel diagnostic test, called MTBDRsl, is a DNA-based test that identifies genetic mutations in MDR-TB strains. At less than US$ 1000 per patient, the new treatment regimen can be completed in 9–12 months.
From: http://redirect.viglink.com?u=http%3A%2F%2Fwww.who.int%2Fentity%2Fmediacentre%2Fnews%2Freleases%2F2016%2Fmultidrug-resistant-tuberculosis%2Fen%2Findex.html&key=ddaed8f51db7bb1330a6f6de768a69b8
No comments:
Post a Comment